Earnings calendar/CLRB
Cellectar Biosciences, Inc. (CLRB)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 12, 2026
Consensus estimate row
EPS target
$-0.46
Street estimate
Revenue target
$17.0M
Street estimate
Trailing EPS (avg 4Q)
$-0.96
Beat rate last 4: 75%
Latest EPS YoY
+83.2%
vs 2025-08-14
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
—
Printed quarters
EPS beat rate (4Q)
75%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 13, 2026
EPS miss
EPS actual / est
$-0.57 / $-0.52
-9.6%
Revenue actual / est
— / $12.0M
—
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/12/2026upcoming | $-0.46 | Pending | — | $17.0M | Pending | — |
| 8/13/2026 | $-0.52 | $-0.57 | -9.6% | $12.0M | Pending | — |
| 5/14/2026 | $-1.89 | $-1.33 | +29.4% | $8.0M | Pending | — |
| 5/12/2026upcoming | $-1.89 | Pending | — | $8.0M | Pending | — |
| 3/12/2026upcoming | $-1.20 | Pending | — | — | Pending | — |
| 3/4/2026 | $-1.19 | $-0.53 | +55.5% | $12.8M | Pending | — |
| 11/17/2025upcoming | $-1.91 | Pending | — | — | Pending | — |
| 11/13/2025 | $-1.91 | $-1.41 | +26.2% | — | Pending | — |
| 8/14/2025 | $-3.60 | $-3.39 | +5.8% | — | Pending | — |
| 5/13/2025 | $-5.11 | $-3.90 | +23.7% | — | Pending | — |
| 3/13/2025 | $-0.38 | $-0.01 | +97.4% | — | Pending | — |
| 11/18/2024 | $-0.35 | $-16.52 | -4586.5% | — | Pending | — |
| 10/29/2024 | $-0.37 | $-0.51 | -37.8% | — | Pending | — |
| 8/13/2024 | $-0.23 | $-5.40 | -2247.8% | — | Pending | — |
| 5/14/2024 | $-15.02 | $-12.01 | +20.0% | — | Pending | — |
| 3/27/2024 | $-1.00 | $-19.82 | -1882.0% | — | Pending | — |
| 11/13/2023 | $-13.21 | $-24.62 | -86.4% | — | Pending | — |
| 8/14/2023 | $-0.69 | $-0.73 | -5.8% | — | Pending | — |
| 5/4/2023 | $-0.75 | $-0.76 | -1.3% | — | Pending | — |
| 3/9/2023 | $-0.83 | $-0.55 | +33.7% | — | Pending | — |
| 11/3/2022 | $-1.21 | $-1.28 | -5.8% | — | Pending | — |
| 8/5/2022 | $-1.08 | $-1.22 | -13.0% | — | Pending | — |
| 5/10/2022 | $-1.10 | $-1.00 | +9.1% | — | Pending | — |
| 3/21/2022 | $-1.00 | $-1.00 | 0.0% | — | Pending | — |
| 11/8/2021 | $-1.10 | $-1.00 | +9.1% | — | Pending | — |
| 8/9/2021 | $-1.10 | $-1.10 | 0.0% | — | Pending | — |
| 5/10/2021 | $-0.90 | $-1.30 | -44.4% | — | Pending | — |
| 3/2/2021 | $-1.50 | $-0.70 | +53.3% | — | Pending | — |
| 11/9/2020 | $-1.50 | $-1.50 | 0.0% | — | Pending | — |
| 8/10/2020 | $-3.00 | $-2.60 | +13.3% | — | Pending | — |
| 5/7/2020 | $-3.40 | $-4.20 | -23.5% | — | Pending | — |
| 3/9/2020 | $-3.60 | $-3.30 | +8.3% | — | Pending | — |
| 11/12/2019 | $-3.80 | $-4.20 | -10.5% | — | Pending | — |
| 8/12/2019 | $-6.00 | $-4.60 | +23.3% | — | Pending | — |
| 5/6/2019 | $-5.00 | $-7.60 | -52.0% | — | Pending | — |
| 2/26/2019 | $-10.00 | $-6.20 | +38.0% | — | Pending | — |
| 11/13/2018 | $-8.30 | $-16.50 | -98.8% | — | Pending | — |
| 8/10/2018 | $-21.00 | $-16.90 | +19.5% | — | Pending | — |
| 5/11/2018 | $-20.00 | $-21.00 | -5.0% | — | Pending | — |
| 3/21/2018 | $-23.00 | $-3400.00 | -14682.6% | — | Pending | — |
| 11/9/2017 | $-25.00 | $-26.00 | -4.0% | — | Pending | — |
| 8/14/2017 | $-24.00 | $-23.00 | +4.2% | — | Pending | — |
| 5/11/2017 | $-23.00 | $-24.00 | -4.3% | — | Pending | — |
| 3/15/2017 | $-23.00 | $-35.00 | -52.2% | — | Pending | — |
| 11/10/2016 | $-20.00 | $-43.00 | -115.0% | — | Pending | — |
| 8/11/2016 | $-40.00 | $-49.00 | -22.5% | — | Pending | — |